View in EDS HTML Full Text PDF Full Text

fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study.

Saved in:
Bibliographic Details
Title: fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study.
Authors: Čižnár, Peter1 (AUTHOR), Roderick, Marion2 (AUTHOR), Schneiderova, Helen3 (AUTHOR), Jeseňák, Miloš4 (AUTHOR), Kriván, Gergely5 (AUTHOR), Brodszki, Nicholas6 (AUTHOR), Jolles, Stephen7 (AUTHOR), Atisso, Charles8 (AUTHOR), Fielhauer, Katharina9 (AUTHOR), Saeed-Khawaja, Shumyla8 (AUTHOR), McCoy, Barbara9 (AUTHOR), Yel, Leman8,10 (AUTHOR) lyel@uci.edu
Source: Allergy, Asthma & Clinical Immunology. 9/17/2024, Vol. 20 Issue 1, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17101484
DOI:10.1186/s13223-024-00904-9